Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.
BACKGROUND: The aim of this clinical trial was to evaluate the effects of febuxostat (FBX) in comparison with hydroxychloroquine (HCQ) on clinical symptoms, laboratory